Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Friday, September 27, 2013

Bioheart, Inc. Announces Positive Preliminary Data From Phase I Angel Trial

Bioheart, Inc. , a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage, announced today preliminary data from its phase I ANGEL Trial.

http://www.biospace.com/news_story.aspx?StoryID=310049&full=1

No comments:

Post a Comment

Popular Stem Cell Roundup Posts